ConductScience.org, home

Trials

Open

611,552 trials from ClinicalTrials.gov. Counted 2026-11-12.

611,552 trials

Newest registered first981 to 1,000 of 611,552

Show the results as
TrialPhaseStatusSponsorResults posted
Pucotenlimab, Lenvatinib, and SBRT Before Surgery for Localized Clear Cell Renal Cell Carcinoma

NCT07922915

Phase 2Not yet recruitingSun Yat-sen University
Toripalimab and Lenvatinib With or Without SBRT Before Surgery for Non-Clear Cell Kidney Cancer

NCT07922928

Phase 2Not yet recruitingSun Yat-sen University
Femoral and Sciatic Nerve Blocks Added to Obturator Nerve Block for Prevention of Obturator Reflex

NCT07922941

Not applicableNot yet recruitingTuna Erturk
Thymosin Alpha 1 and IgM Levels in Sepsis

NCT07922954

Phase 4Active not recruitingSoutheast University, China
Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial

NCT07922967

RecruitingOslo University Hospital
Usability of the FTEXES Wearable Textile Platform for Functional Electrical Stimulation and EMG

NCT07922980

Not applicableNot yet recruitingPolitecnico di Milano
Effectiveness of a Nurse-Led Transitional Care Model Based on the Fundamentals of Care Framework

NCT07922993

Not applicableCompletedUniversity of Rome Tor Vergata
Effects of Resistance Exercise on Enthesitis in Patients With Spondyloarthritis

NCT07923006

Not applicableActive not recruitingSisli Hamidiye Etfal Training and Research Hospital
BRIGHT-LIGHT: Studying Red Light Therapy for Severe Short-Sightedness or Short-Sightedness That Worsens Despite Standard Treatment

NCT07923019

Not applicableNot yet recruitingSingapore National Eye Centre
Low-Intensity Focused Ultrasound for Gambling Disorder

NCT07923032

Not applicableNot yet recruitingUniversity of Virginia
A Phase 1/2, Single-Dose, Multicenter, Dose Escalation, Clinical Trial to Evaluate the Safety and Efficacy of MR-146: An Open-Label Part 1 in Participants With Stage 1 or 2 Neurotrophic Keratopathy and a Double-Masked Part 2 in Participants With Stage 2 Neurotrophic Keratopathy

NCT07923045

Phase 1, Phase 2RecruitingViatris Inc.
Clinical Trial of SEEG for Drug-resistant Epilepsy

NCT07923058

Not applicableNot yet recruitingBeijing Pins Medical Co., Ltd
A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment

NCT07923071

Phase 1Not yet recruitingSyndax Pharmaceuticals
Determining the Clinical Impact and Prevalence of Hemorrhagic Subtypes in Perimesencephalic Subarachnoid Hemorrhage

NCT07923084

RecruitingInsel Gruppe AG, University Hospital Bern
Study Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable.

NCT07923097

Phase 1RecruitingRapport Therapeutics Inc.
Post-operative Pain and Clinical Outcome After Single-cone Obturation With a Calcium Silicate-based Versus Epoxy Resin Sealer

NCT07923110

Not applicableNot yet recruitingUniversity Ghent
Effects of Acupressure and Progressive Relaxation Exercises on Sleep and Comfort in Rhinoplasty Patients

NCT07923123

Not applicableCompletedAltinbas University
Validation of Uzbek SARC-F and IPAQ-SF Questionnaires in Adults With and Without Hypothyroidism

NCT07923136

Not yet recruitingAndijan State Medical Institute
Split-Belt Treadmill Training to Improve Walking After Hip Fracture

NCT07923149

Not applicableCompletedIsrael Dudkiewicz
MACE and BTK Inhibitors

NCT07923162

Phase 4Not yet recruitingUniversity Hospital, Caen

Request

GET /api/trials/v1

Words from a trial's title, conditions, interventions, sponsor or registered outcomes, its NCT number, or another registry's ID.

Only the trials that posted results to ClinicalTrials.gov.

A ConductCognition test's ID, such as stroop: only the trials whose registered outcomes name that test, primary outcome first.

No key needed

Response

The first 2 of this page's 20 results. GET /api/trials/v1?page=50

{
  "data": {
    "total": 611552,
    "results": [
      {
        "id": "NCT07922915",
        "title": "Pucotenlimab, Lenvatinib, and SBRT Before Surgery for Localized Clear Cell Renal Cell Carcinoma",
        "summary": "NCT07922915, Phase 2, Not yet recruiting, Sun Yat-sen University",
        "record": "/library/trials/NCT07922915",
        "nct_id": "NCT07922915",
        "phase": "Phase 2",
        "status": "Not yet recruiting",
        "sponsor": "Sun Yat-sen University",
        "results_first_posted": null
      },
      {
        "id": "NCT07922928",
        "title": "Toripalimab and Lenvatinib With or Without SBRT Before Surgery for Non-Clear Cell Kidney Cancer",
        "summary": "NCT07922928, Phase 2, Not yet recruiting, Sun Yat-sen University",
        "record": "/library/trials/NCT07922928",
        "nct_id": "NCT07922928",
        "phase": "Phase 2",
        "status": "Not yet recruiting",
        "sponsor": "Sun Yat-sen University",
        "results_first_posted": null
      }
    ],
    "columns": [
      {
        "key": "title",
        "label": "Trial",
        "under": "nct_id"
      },
      {
        "key": "phase",
        "label": "Phase"
      },
      {
        "key": "status",
        "label": "Status"
      },
      {
        "key": "sponsor",
        "label": "Sponsor"
      },
      {
        "key": "results_first_posted",
        "label": "Results posted"
      }
    ],
    "order": "Newest registered first",
    "kinds": {
      "all": 611552,
      "with-results": 77078
    }
  },
  "release": "trials-2026-11-12-0.4.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "None stated"
    },
    {
      "source": "NIH RePORTER's clinical studies and project files",
      "license": "Public domain (NIH RePORTER)",
      "short": "Public domain"
    }
  ],
  "next": "/api/trials/v1?page=51",
  "request_id": "jyI7VZICdIU2nUef"
}
trials-2026-11-12-0.4.0Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trial comparisons

ClinicalTrials.gov

Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.

Open85,013 comparisons2026-11-10

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trials from software.

Every answer on this page is also JSON, under /api/trials/v1. No key.

GET https://conductscience.org/api/trials/v1?q=vutrisiran&kind=with-results

Ask an assistant

  • Which trials of vutrisiran posted results, and who sponsored them?
  • Which trials name the Stroop test as a primary outcome?
  • What adverse events did HELIOS-B report in each group?
  • Which trials of semaglutide in heart failure posted results?